Workflow
BIC: Disclosure Of Trading In Own Shares for January 2026
Globenewswire· 2026-02-05 16:45
Disclosure Of Trading In Own Shares for January 2026 Clichy, France – February 05, 2026 In compliance with general regulation on share buy-backs, Société BIC declares below the transactions made on its own shares for January 2026: - No transactions for January 2026. Contacts Brice ParisVP Investor Relations +33 6 42 87 54 73brice.paris@bicworld.com Investor Relationsinvestors.info@bicworld.com Bethridge ToovellVP Global Communications+1 917 821 4249bethridge.toovell@bicworld.com Isabelle de Segonzac Ima ...
VINCI: 2025 full year results - Outstanding performance, record free cash flow
Globenewswire· 2026-02-05 16:45
Nanterre, 5 February 2026 OUTSTANDING PERFORMANCE – RECORD FREE CASH FLOW Revenue growth: €74.6 billion (+4%) - operating earnings up for each of the Group’s three businesses: Concessions, Energy Solutions and ConstructionIncrease in net income: €4.9 billion (+1% and +10% excluding the exceptional tax contribution) Record free cash flow: €7.0 billion2026 outlook: further revenue and earnings growth expected Dividend proposed with respect to 2025: €5.00 per share (up €0.25 compared with 2024) Pierre Anjolr ...
Sales are Underway at New Waterfront Townhome Community by Toll Brothers, 400 Lake at Asbury Park, in New Jersey
Globenewswire· 2026-02-05 16:42
ASBURY PARK, N.J., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, today announced that sales are underway at 400 Lake at Asbury Park, a brand-new community of waterfront townhomes in Asbury Park, New Jersey. The Toll Brothers Sales Center, located at 400 Cookman Avenue in Asbury Park, is now open. 400 Lake at Asbury Park features 3- and 4-story modern townhomes with open floor plans and rooftop terraces with ocean and lake views. Located just ...
Festi hf.: 2025 Annual report
Globenewswire· 2026-02-05 16:29
End of a strong year for Festi: Strong operational performance in the quarter and the results for the year significantly exceeded the company's initial guidance. Main results in Q4 2025 Sales of goods and services amounted to ISK 44,956 million, an increase of 7.2% between years.Margin from sales of goods and services amounted to ISK 11,415 million, an increase of 11.2% from the previous year.Profit margin was 25.4%, decreases by 0.2 p.p. from Q3 2025 but increases by 0.9 from Q4 2024.EBITDA amounted to ISK ...
Virbac : Declaration of the number of shares and voting rights 01/2026
Globenewswire· 2026-02-05 16:29
DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital (Article 223-16 of the General regulations of the French Financial Market Authority – Autorité des Marchés Financiers) Quotation place: Euronext ParisCompartiment AISIN code: FR0000031577 DateTotal number of shares representing the share capitalTotal number of voting rightsJanuary, 31 20268 390 660Gross total of voting rights : 12 704 131Net total* of voting rig ...
Divestment of aerospace business to SpaceX
Globenewswire· 2026-02-05 16:29
(Oslo, Norway, 5 February 2025) Hexagon Purus ASA ("Hexagon Purus" or the “Company”), a world leading manufacturer of zero-emission mobility and infrastructure solutions, has through one of its wholly owned subsidiaries entered into an agreement to divest its aerospace business to Space Exploration Technologies Corp. (“SpaceX”). The transaction comprises the sale of 100% of the shares of Hexagon Masterworks Inc. (“Masterworks”), which supplies high-pressure composite storage cylinders for aerospace and spac ...
Petrus Resources Announces Upsize of Bought Deal Life Offering to $14.5 Million
Globenewswire· 2026-02-05 16:18
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR PUBLIC DISSEMINATION IN THE UNITED STATES. CALGARY, Alberta, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Petrus Resources Ltd. ("Petrus" or the "Company") (TSX: PRQ) is pleased to announce that, due to investor demand, it has entered into an amended agreement with Haywood Securities Inc. on behalf of a syndicate of underwriters (collectively, the "Underwriters"), to increase the size of its previously announced "bought deal" private placement offering to approximately ...
PodcastOne (Nasdaq: PODC) Renews Bitch Bible, Some More News and The Prosecutors, Acquires For Your Amusement In Multi-Year Agreement
Globenewswire· 2026-02-05 16:09
Podcasts Combine for Over 30 Million Downloads Across Network, For Your Amusement Marks 25th New Podcast for 2026 Fiscal YearLOS ANGELES, Feb. 05, 2026 (GLOBE NEWSWIRE) -- PodcastOne (Nasdaq: PODC), a leading publisher and podcast sales network, announced today that it entered into a multiyear extension with The Prosecutors, as well as renewal agreements with Bitch Bible and Some More News. Additionally, PodcastOne has acquired the sales and distribution rights to For Your Amusement in a multiyear deal. Hos ...
Oma Savings Bank Plc: The Financial Supervisory Authority has initiated a hearing procedure concerning imposing possible administrative sanctions on Oma Savings Bank Plc
Globenewswire· 2026-02-05 16:00
OMA SAVINGS BANK PLC, STOCK EXCHANGE RELEASE ON 5 FEBRUARY 2026 AT 18.00 P.M. EET, INSIDER INFORMATION Oma Savings Bank Plc: The Financial Supervisory Authority has initiated a hearing procedure concerning imposing possible administrative sanctions on Oma Savings Bank Plc Oma Savings Bank Plc (OmaSb or the Company) announced on 3 May 2024 that the Financial Supervisory Authority had filed a request for a police investigation concerning suspected securities market offences related to the Company and was conc ...
Novo Nordisk issues statement on illegal mass compounding and deceptive advertising by Hims & Hers
Globenewswire· 2026-02-05 15:46
Bagsværd, Denmark and Plainsboro, NJ, 5 February 2026 – Novo Nordisk today issued the following statement regarding the announcement by Hims & Hers that they will unlawfully mass-market an unapproved, inauthentic, and untested knockoff semaglutide pill. “The action by Hims & Hers is illegal mass compounding that poses a significant risk to patient safety. Novo Nordisk will take legal and regulatory action to protect patients, our intellectual property and the integrity of the US gold-standard drug approval ...